DrugNews Update Shows 6% Rise In Pradaxa Lawsuits Alleging Internal Bleeding

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Last month, a report ranked Pradaxa highest in the number of side effect complaints to the FDA last year, with 683 reports of bleeding.

Dallas, TX (PRWEB) November 27, 2013

The DrugNews.net prescription drug safety center is announcing updated information on the site for patients taking the blood thinner Pradaxa. New court records show the number of lawsuits alleging internal bleeding injury or death from the drug have grown 6% in November*.

DrugNews is a resource site for those taking popular prescription drugs. By sharing the latest medication recalls, safety alerts, research and litigation news, patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is an anticoagulant, or blood thinner, which was approved by the FDA in 2010. It is prescribed to patients with atrial fibrillation to prevent blood clots and stroke. While the FDA has stated Pradaxa is as safe as traditional blood thinner warfarin**, other experts disagree.

The Institute for Safe Medication Practices has warned that patients may be nearly 5 times as likely to die from Pradaxa bleeding than from warfarin bleeding***. A study this year from Europe also discovered patients taking anticoagulants like Pradaxa could be 55% more likely to suffer internal bleeding****.

Last month, a report ranked Pradaxa highest in the number of side effect complaints to the FDA last year, with 683 reports of bleeding*****.

With the number of patients who have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugNews has added the latest court records from the Judicial Panel on Multidistrict Litigation, which show the number of cases filed has increased over 6% in a month, from 1,643 on October 17 to 1,748 on November 18th*.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*JPML, 11/18/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-November-18-2013.pdf
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
*****Institute for Safe Medication Practices, 10/17/13; ismp.org/quarterwatch/pdfs/2012Q4.pdf


Contact